The global multi-use bioreactors market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for biopharmaceuticals and CROs in emerging economies such as China and India. The increasing number of clinical trials in these countries has led to an increase in the demand for multi-use bioreactors, which are used for various applications such as cell culture, fermentation, and purification. The 50L type segment accounted for the largest share of the global multi-use bioreactors market in 2018 due to its low cost and easy availability. However, it is expected that by 2030, 10250L type will account for a larger share due to its high productivity rate and ability to produce large volumes of product per batch cycle. -The global Multiple-use Bioreactors market is expected to grow at a CAGR of 6.5% during the forecast period, 2018-2025. -The global Multiple-use Bioreactors market is expected to reach USD 3.2 billion by 2025 from USD 2.1 billion in 2018, growing at a CAGR of 6.5%. -Increasing demand for biopharmaceuticals and increasing research and development activities are the major drivers for the growth of this market.
Industry Growth Insights published a new data on “Multiple-use Bioreactors Market”. The research report is titled “Multiple-use Bioreactors Market research by Types (0-50L, 50-100L, 100-250L, Above 250L), By Applications (Biopharmaceutical Companies, CROs, Academic and Research Institutes, Others), By Players/Companies Thermo Fisher, Merck KGaA, Danaher (Pall), GE Healthcare, Sartorius AG (BBI), ZETA, Eppendorf AG, Pierre Guerin (DCI-Biolafitte), Praj Hipurity Systems, Bioengineering AG, Infors HT, Applikon Biotechnology, Solaris”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Multiple-use Bioreactors Market Research Report
By Type
0-50L, 50-100L, 100-250L, Above 250L
By Application
Biopharmaceutical Companies, CROs, Academic and Research Institutes, Others
By Companies
Thermo Fisher, Merck KGaA, Danaher (Pall), GE Healthcare, Sartorius AG (BBI), ZETA, Eppendorf AG, Pierre Guerin (DCI-Biolafitte), Praj Hipurity Systems, Bioengineering AG, Infors HT, Applikon Biotechnology, Solaris
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Multiple-use Bioreactors Market Report Segments:
The global Multiple-use Bioreactors market is segmented on the basis of:
Types
0-50L, 50-100L, 100-250L, Above 250L
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Companies, CROs, Academic and Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher
- Merck KGaA
- Danaher (Pall)
- GE Healthcare
- Sartorius AG (BBI)
- ZETA
- Eppendorf AG
- Pierre Guerin (DCI-Biolafitte)
- Praj Hipurity Systems
- Bioengineering AG
- Infors HT
- Applikon Biotechnology
- Solaris
Highlights of The Multiple-use Bioreactors Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 0-50L
- 50-100L
- 100-250L
- Above 250L
- By Application:
- Biopharmaceutical Companies
- CROs
- Academic and Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Multiple-use Bioreactors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A multiple-use bioreactor is a type of bioreactor that can be used for more than one purpose. Multiple-use bioreactors are often used to produce biofuels, pharmaceuticals, and other products.
Some of the major players in the multiple-use bioreactors market are Thermo Fisher, Merck KGaA, Danaher (Pall), GE Healthcare, Sartorius AG (BBI), ZETA, Eppendorf AG, Pierre Guerin (DCI-Biolafitte), Praj Hipurity Systems, Bioengineering AG, Infors HT, Applikon Biotechnology, Solaris.
The multiple-use bioreactors market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Multiple-use Bioreactors Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Multiple-use Bioreactors Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Multiple-use Bioreactors Market - Supply Chain
4.5. Global Multiple-use Bioreactors Market Forecast
4.5.1. Multiple-use Bioreactors Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Multiple-use Bioreactors Market Size (000 Units) and Y-o-Y Growth
4.5.3. Multiple-use Bioreactors Market Absolute $ Opportunity
5. Global Multiple-use Bioreactors Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Multiple-use Bioreactors Market Size and Volume Forecast by Type
5.3.1. 0-50L
5.3.2. 50-100L
5.3.3. 100-250L
5.3.4. Above 250L
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Multiple-use Bioreactors Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Multiple-use Bioreactors Market Size and Volume Forecast by Application
6.3.1. Biopharmaceutical Companies
6.3.2. CROs
6.3.3. Academic and Research Institutes
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Multiple-use Bioreactors Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Multiple-use Bioreactors Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Multiple-use Bioreactors Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Multiple-use Bioreactors Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Multiple-use Bioreactors Demand Share Forecast, 2019-2029
9. North America Multiple-use Bioreactors Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Multiple-use Bioreactors Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Multiple-use Bioreactors Market Size and Volume Forecast by Application
9.4.1. Biopharmaceutical Companies
9.4.2. CROs
9.4.3. Academic and Research Institutes
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Multiple-use Bioreactors Market Size and Volume Forecast by Type
9.7.1. 0-50L
9.7.2. 50-100L
9.7.3. 100-250L
9.7.4. Above 250L
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Multiple-use Bioreactors Demand Share Forecast, 2019-2029
10. Latin America Multiple-use Bioreactors Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Multiple-use Bioreactors Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Multiple-use Bioreactors Market Size and Volume Forecast by Application
10.4.1. Biopharmaceutical Companies
10.4.2. CROs
10.4.3. Academic and Research Institutes
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Multiple-use Bioreactors Market Size and Volume Forecast by Type
10.7.1. 0-50L
10.7.2. 50-100L
10.7.3. 100-250L
10.7.4. Above 250L
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Multiple-use Bioreactors Demand Share Forecast, 2019-2029
11. Europe Multiple-use Bioreactors Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Multiple-use Bioreactors Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Multiple-use Bioreactors Market Size and Volume Forecast by Application
11.4.1. Biopharmaceutical Companies
11.4.2. CROs
11.4.3. Academic and Research Institutes
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Multiple-use Bioreactors Market Size and Volume Forecast by Type
11.7.1. 0-50L
11.7.2. 50-100L
11.7.3. 100-250L
11.7.4. Above 250L
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Multiple-use Bioreactors Demand Share, 2019-2029
12. Asia Pacific Multiple-use Bioreactors Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Multiple-use Bioreactors Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Multiple-use Bioreactors Market Size and Volume Forecast by Application
12.4.1. Biopharmaceutical Companies
12.4.2. CROs
12.4.3. Academic and Research Institutes
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Multiple-use Bioreactors Market Size and Volume Forecast by Type
12.7.1. 0-50L
12.7.2. 50-100L
12.7.3. 100-250L
12.7.4. Above 250L
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Multiple-use Bioreactors Demand Share, 2019-2029
13. Middle East & Africa Multiple-use Bioreactors Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Multiple-use Bioreactors Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Multiple-use Bioreactors Market Size and Volume Forecast by Application
13.4.1. Biopharmaceutical Companies
13.4.2. CROs
13.4.3. Academic and Research Institutes
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Multiple-use Bioreactors Market Size and Volume Forecast by Type
13.7.1. 0-50L
13.7.2. 50-100L
13.7.3. 100-250L
13.7.4. Above 250L
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Multiple-use Bioreactors Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Multiple-use Bioreactors Market: Market Share Analysis
14.2. Multiple-use Bioreactors Distributors and Customers
14.3. Multiple-use Bioreactors Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck KGaA
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Danaher (Pall)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. GE Healthcare
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Sartorius AG (BBI)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. ZETA
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Eppendorf AG
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pierre Guerin (DCI-Biolafitte)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Praj Hipurity Systems
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Bioengineering AG
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Infors HT
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Applikon Biotechnology
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Solaris
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook